Personalized Tumorgrafts represent a novel approach to personalized cancer treatment and are showing promise in predicting a patient's clinical response to drug therapies. A Personalized Tumorgraft is a sample of the patient's living tumor that is grown and tested in our facilities. By utilizing the Personalized Tumorgraft implantation program, the cancer treatment selected for the patient by his/her physician may be more likely to be successful, sparing the patient from undergoing therapy that may not be optimal for that specific cancer. Importantly, Champions maintains the patient's living Tumorgraft for future testing studies as the patient's condition changes, new technologies emerge, or in case a family member is diagnosed with cancer.
Is the Personalized Tumorgraft program like a clinical trial?
No. A Personalized Tumorgraft represents cutting-edge medicine. However, it is like an individualized, personal clinical trial customized for an individual patient. The added value of the Personalized Tumorgraft is that a patient can also contribute to the knowledge gained from clinical trials without actually participating in clinical trials, simply by providing their tumor tissue. A number of special studies can be performed on a surrogate for the person's tumor rather than on the person themselves, regardless of eligibility requirements for clinical trials. And, since Personalized Tumorgrafts are banked as living samples for future testing, the patient may have the benefit of additional testing opportunities when future drug discoveries are made.
What types of cancer have been implanted as part of the Champions Personalized Tumorgraft program?
The following cancer types have been implanted using the Champions Personalized Tumorgraft™ program: Pancreas, Sarcoma, Melanoma, Liver, Lung, Breast, Colon and other rare tumor types.
LOGIN TO LEARN MORE